BeiGene USA, Inc.赞助的临床试验
总计827个结果
-
Fibronostics USA, IncOBVIO HEALTH USA, Inc.撤销
-
Senju USA, Inc.完全的
-
MEDRx USA, Inc.完全的
-
MetaCure (USA), Inc.完全的
-
AnGes USA, Inc.招聘中
-
Ribomic USA Inc完全的
-
Fibronostics USA, Inc完全的
-
AnGes USA, Inc.终止
-
USDA, Western Human Nutrition Research CenterAjinomoto USA, INC.完全的
-
HeartBeam, Inc.Meditrial USA Inc.尚未招聘
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology Consortium招聘中胶质母细胞瘤 | 恶性胶质瘤 | 复发性胶质母细胞瘤 | 复发性 WHO III 级神经胶质瘤 | WHO III 级神经胶质瘤 | IDH2基因突变 | IDH1基因突变 | 低级别胶质瘤 | 复发性 WHO II 级神经胶质瘤 | WHO II 级神经胶质瘤美国
-
Leap Therapeutics, Inc.BeiGene主动,不招人
-
BeiGeneMyriad Genetics, Inc.完全的
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; BeiGene USA, Inc.; Roche-Genentech招聘中慢性淋巴细胞白血病 (CLL) | 小淋巴细胞白血病 (SLL)美国